About Us

Markets advance to close modestly higher

The markets advanced in late afternoon trading to close modestly higher with the Dow rising 14 points to 19,933. Nasdaq gained 15 points to 5,462.


On the upside


The Food and Drug Administration accepted Portola Pharmaceuticals' (Nasdaq: PTLA) New Drug Application for betrixaban.


Bargain hunters lifted shares of Conatus Pharmaceuticals (Nasdaq: CNAT).


A district court granted a stay of judgment in a verdict against Neovasc (Nasdaq: NVCN).


On the downside


Shares of Pengrowth Energy (NYSE: PGH) extended its losses.


GNC Holdings (NYSE: GNC) stock continued to fall.


Investors locked in profits on Opexa Therapeutics (Nasdaq: OPXA).


In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 index added 2 points to 2,263. Bitcoin surged $45 to $900.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.